Prophylactic Versus Therapeutic Sucralfate in Patients at High Risk for Radiation Esophagitis: Randomized Controlled...

Area of Science:

• Oncology
• Radiation Oncology
• Gastroenterology

Background:

• Radiation esophagitis (RE) is a common and painful side effect of thoracic radiotherapy.
• Opioid pain medication is frequently required for managing RE symptoms.
• Patients at high risk for RE may benefit from prophylactic interventions.

Purpose of the Study:

• To investigate the efficacy of prophylactic sucralfate in reducing opioid pain medication use in patients at high risk for radiation esophagitis.
• To assess the impact of prophylactic sucralfate on the severity of radiation esophagitis.

Main Methods:

• A randomized trial involving patients at high risk for RE undergoing radiotherapy.
• Patients received either prophylactic sucralfate or standard supportive care.
• Opioid use and RE severity were compared between the two groups.

Main Results:

• The study was terminated early due to a lack of observed differences between the sucralfate and control groups.
• Opioid use rates were similar in both groups (30%).
• Rates of grade 2-3 RE were non-significantly lower in the sucralfate arm (59% vs. 69%).

Conclusions:

• Prophylactic sucralfate did not demonstrate a significant benefit in reducing opioid use or the severity of RE.
• Further research is needed to identify effective treatments for radiation esophagitis due to limited current options.